Loading clinical trials...
Loading clinical trials...
The goal of this clinical trial is to test ATX-01 in participants with myotonic dystrophy type 1 (DM1). The main question it aims to answer is if ATX-01 is safe and well tolerated. The trial will comp...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
ARTHEx Biotech S.L.
NCT05532813 · Steinert's Disease, Myotonic Dystrophy 1, and more
NCT07136844 · Neuromuscular Diseases, Obesity (Disorder), and more
NCT02398786 · Myotonic Dystrophy, Congenital Myotonic Dystrophy, and more
NCT07008469 · Myotonic Dystrophy Type 1, DM1, and more
NCT06101940 · Myotonic Dystrophy 1
UCLA
Los Angeles, California
University of Florida
Gainesville, Florida
University of Iowa Health Care - Department of Neurology
Iowa City, Iowa
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions